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ABSTRACT 
Introduction: In vivo fluorescence imaging can quantify vascular permeability 
without requiring sacrifice of animals. However, use of this noninvasive approach for 
vascular permeability assessment in remote organ injury caused by systemic 
inflammatory disease has not been reported.  
Methods: Evans blue (EB) and Genhance 750 fluorescent dye were mixed and 
injected into mice. The lung as a remote organ and the footpad as a noninvasive 
observational site were assessed in a cecal ligation and puncture (CLP)-induced 
systemic inflammation mouse model and compared with sham and hydrocortisone 
pretreated (CLP + HC) mouse models. Extraction of EB in harvested tissues was 
assessed as a conventional indicator of vascular permeability. Fluorescent intensities 
in the footpad or harvested lung were assessed and their correlation was analyzed to 
investigate this novel, noninvasive approach for estimation of lung vascular 
permeability. 
Results: Fluorescent intensity in the footpad and harvested lung in the CLP group was 
significantly higher than in the other groups (footpad, sham vs. CLP, P<0.0001; CLP 
vs. CLP + HC, P=0.0004; sham vs. CLP + HC, P=0.058; lung, sham vs. CLP, 
P<0.0001; CLP vs. CLP + HC, P<0.0001; sham vs. CLP + HC, P=0.060). The 
fluorescent intensity in the footpad was strongly correlated with that in the lung 
(r=0.95).  
Conclusions: This fluorescent technique may be useful for vascular permeability 
assessment based on EB quantification. Footpad fluorescent intensity was strongly 
correlated with that in the lung, and may be a suitable indicator in noninvasive 
estimation of lung vascular permeability. 
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Introduction 
Vascular permeability increases in patients with systemic inflammation caused 
by sepsis (1, 2). This biological response to sepsis may be protective through 
enhancement of neutrophil migration to an infection site (1). However, the associated 
systemic leakage of fluid and molecules from the intravascular space leads to edema 
in remote tissues and organs (2), and can impair their function (3). Since there is 
accumulating evidence that increased vascular permeability may worsen clinical 
outcomes in septic shock (4, 5), there is a need to develop therapeutic approaches to 
control vascular permeability and thereby improve outcomes (6, 7). 
Vascular permeability has been investigated in vivo using animal models of 
sepsis (8, 9). In these studies, vascular permeability has been quantified by measuring 
injected reagents such as Evans blue (EB) dye extracted from the tissue after sacrifice 
(8, 9). This invasive approach requires harvested tissue, and does not allow evaluation 
of temporal changes or responses to therapeutic drugs in a single individual; this 
becomes a barrier to development of therapeutic approaches to vascular 
hyperpermeability in preclinical in vivo studies.  
Real-time in vivo fluorescence imaging potentially quantifies vascular 
permeability without requiring sacrifice of animals (10, 11). It has been reported that 
intravital microscopic imaging with fluorescent dye can directly demonstrate vascular 
leakage in lungs with lung exposure (12). Optical fluorescence imaging technique 
might facilitate noninvasive longitudinal investigation of superficial vascular 
permeability (10, 13). In addition, use of a near-infrared (NIR) fluorescent dye with 
features of deep tissue penetration, minimum interference from background 
biomolecular autofluorescence in living systems, and low light scattering (14), 
enables more accurate in vivo fluorescent imaging without artifacts. However, the use 
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of this noninvasive approach to quantify vascular permeability in remote organs 
caused by systemic inflammatory disease such as sepsis has not been reported. 
Thus, we hypothesized that a noninvasive approach with in vivo fluorescence 
imaging can be used to investigate vascular permeability in remote organs during 
sepsis. We used a cecal ligation and puncture (CLP) mouse model, and measured 
fluorescence intensity in the lung as a remote organ and in the footpad.  
 
 
Materials and Methods 
Reagents 
EB dye (Sigma-Aldrich Co. LLC., St. Louis, MO, USA) was used to 
measure vascular permeability with a conventional assay technique (8, 15-17). 
Genhance 750, a near-infrared (NIR) fluorescent dye with peak fluorescence 
excitation at 750 ± 5 nm and emission of 775 ± 5 nm, low molecular weight of 1,086, 
blood half-life of 30 min in healthy mice, and renal excretion was used to develop an 
assay based on in vivo fluorescence imaging (PerkinElmer Inc., Waltham, MA, USA). 
We chose Genhance 750 for two reasons. According to a previous report, dyes with 
large-size particles (diameter >0.84 μm) cannot penetrate the extravascular 
inflammatory joint space in arthritic mice (13); however, small molecules can leak 
across the vascular barrier under conditions of hyperpermeability. Therefore, a dye 
with a short half-life reduces fluorescence from the intravascular space that can 
potentially increase background signals (18). EB and Genhance 750 were dissolved in 
phosphate-buffered saline (PBS) in a concentration of 1% w/v and 0.1 mg/mL, 
respectively. Equal amounts of the two dyes were mixed and 100 µL was injected into 
each mouse through the tail vein as previously reported (15, 16). To obtain sufficient 
6 
systemic distribution of dye, we waited 2 min after injection and set this time point as 
the baseline.  
 
Mouse model 
Wild type (male, 8-12-week-old) C57BL/6J mice (CLEA Japan, Inc., Tokyo, 
Japan) were housed under 12-h light-dark cycle, specific pathogen-free conditions, 
and had readily accessible water and food in the animal room at Chiba University, 
Japan. Inhaled isoflurane (5% for induction and 2% for maintenance) was used for 
anesthesia. The Institutional Animal Care and Use Committees of Chiba University 
approved the current study. All experiments were performed with strict adherence to 
National Institutes of Health guidelines. 
 
1. Local inflammation model using mustard oil  
A local inflammation model was studied in 4 mice using a previously 
described inflammatory reagent, mustard oil (17, 19). Briefly, dye mixture (equal 
parts 1% w/v EB and 0.1 mg/mL Genhance 750) were injected into anesthetized mice 
via the tail vein. At 2 min after dye injection, mustard oil with diluted allyl 
isothiocyanate (Tokyo Chemical Industry, Co., Ltd., Tokyo, Japan) in mineral oil (MP 
Biomedicals, LLC., Santa Ana, CA, USA) was applied to the right footpad (control, 
left footpad). Fluorescent imaging of right and left footpads was obtained immediately 
after application (baseline) and 60 min later. After second imaging, mice were 
euthanized and footpad samples were collected by amputation from the ankles. 
Collected samples were flash-frozen in liquid nitrogen and stored at -80°C until 
examination. 
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2. Systemic inflammation model using CLP 
We chose CLP as a systemic inflammation model. Twenty-nine mice (25.0 ± 
1.7 g) were used in this study and randomly assigned to the CLP group, sham group, 
or the CLP + hydrocortisone (HC) group. CLP surgery was performed as previously 
described (16, 20). Briefly, mice were anesthetized under aseptic conditions and 
midline laparotomy was performed. The cecum was exposed and ligated 2 cm from 
the distal end. Two punctures were made with an 18-gauge needle and the cecum was 
gently returned to the abdominal cavity. The abdominal wall was sutured closed in 2 
layers and 2 mL of normal saline was subcutaneously injected. The sham model 
underwent the same procedures but without CLP. The CLP + HC group was preparing 
using hydrocortisone (HC, Pfizer Japan Inc., Tokyo, Japan) administered 
intraperitoneally 30 min before CLP surgery at a dose of 10 mg/kg. Mice awoke after 
surgery and had no limits other than fasting between experiments. The mice were 
observed for 3 h to obtain sufficient vascular permeability (8), and were then 
anesthetized again for dye injection. At 2 min (baseline) and 60 min after dye 
injection, blood samples and fluorescent images were obtained. After blood sampling 
at the 60-min time point, the auricle of the right atrium was incised and sufficiently 
exsanguinated to reduce the effect of remaining blood on the results. Since Genhance 
750 has a low molecular weight and the distribution of small molecules may easily be 
affected by technical factors (21), we did not flush the blood vessels. After 
exsanguination, lung samples were harvested and rinsed in PBS, and fluorescent 
images were obtained. Collected samples were flash-frozen in liquid nitrogen, and 
stored at -80°C until examination. 
 
Vascular permeability assessment  
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EB quantification 
The concentration of EB dye was measured as previously described (8, 15, 
22, 23). Briefly, stored samples were homogenized in 500 µL formamide (Sigma-
Aldrich Co. LLC.) and incubated at 55°C for 24 h to extract EB from the sample 
tissue. After centrifugation (15,000 rpm, 10 min, using MX-107; TOMY SEIKO Co., 
LTD., Tokyo, Japan), the supernatant was collected and the absorbance was measured 
using a SpectraMax M5e microplate reader (Molecular Devices, LLC., Silicon Valley, 
CA, USA) and SoftMax Pro 5.2 software (Molecular Devices, LLC.). The absorbance 
of footpad supernatant was measured at 620 nm (A620) as previously described (22); 
the absorbance of lung supernatant was measured at A620 and 740 nm (A740) to 
correct for the presence of heme pigments: A620 (corrected) = A620 – (1.426 × A740 
+ 0.030), as previously described (8). Extracted EB was calculated using standard 
curves and described as a concentration (µg/mL) in the supernatant.  
 
Fluorescent technique 
Fluorescent intensity was measured using an IVIS Lumina II (PerkinElmer 
Inc.) imaging system with a high-range filter, and analyzed using Living Image 3.1 
software (PerkinElmer Inc.). Images were obtained with filters for excitation at 745 
nm, emission at 800 nm (filters were selected to avoid overlap of fluorescent 
excitation and emission), 5-s exposure, f-stop 2, small binning, from field of view D.  
Images were outlined and fluorescent regions of interest (ROIs) were 
analyzed. Fluorescent intensity was quantified as average efficiency, which is the 
average value of fluorescent emission of an ROI, normalized to the incident excitation 
intensity (24).  
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Fluorescent intensities were measured in both footpads and the averages were 
calculated in the systemic inflammation model in duplicate. The average fluorescent 
intensity of blood was measured with 100 µL of blood instilled into 96-well plates and 
the wells were outlined as an ROI. The fluorescent intensity was evaluated in an 
excised lung after the mouse was sacrificed, and the average was measured in 
adjoining areas of both the right and left lungs; all areas were outlined as ROIs, as 
shown in Figure 3B. 
 
Statistical analysis  
We assessed differences in extracted EB concentration and fluorescent 
intensity in footpads treated with mustard oil and controls using a paired t-test. One-
way analysis of variance (ANOVA) with Tukey’s post hoc test was used to evaluate 
differences in extracted EB concentration and fluorescent intensity of lung, blood, and 
footpad samples in sham, CLP, and CLP + HC groups. Temporal changes in blood 
fluorescent intensity in the sham and CLP groups were analyzed using a paired t-test. 
The correlation between lung and footpad fluorescent intensity was analyzed using 
linear regression and Pearson’s correlation coefficient.  
We evaluated fluorescent intensities at 2 min (baseline) and 60 min for the 
fold change from baseline. Data are expressed as mean ± standard deviation. Two-
tailed P values <0.05 were considered significant. Analyses were performed using 
GraphPad Prism 7 (GraphPad Software, Inc., La Jolla, CA, USA).  
 
 
Results 
1. Vascular permeability in a local inflammation model  
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Vascular permeability in a local inflammation model was measured using 
conventional EB dye and fluorescence imaging methods. In the conventional method, 
the EB concentration extracted from the mustard oil-treated footpads was significantly 
higher than that in control footpads (P=0.024) (Figure 1A); the conventional method 
detected the increased vascular permeability caused by local stimulation with mustard 
oil. Similar to the results with the conventional method, the fold change from baseline 
of fluorescent imaging intensity between 2 min and 60 min in the mustard oil-treated 
footpads was significantly higher than that in control footpads (P=0.0049) (Figure 
1B, 1C). 
 
2. Vascular permeability in a systemic inflammation model 
We next measured vascular permeability in a systemic inflammation model. 
The temporal change in intensity of fluorescent dye in blood was first evaluated 
(Figure 2A); the blood fluorescent intensity significantly decreased at 60 min 
compared with baseline in the sham and CLP groups (sham, P=0.036; CLP, P=0.025) 
(Figure 2B).  
We next measured lung vascular permeability in CLP models using 
conventional EB dye methods and fluorescence imaging. The CLP mice had 
significantly more EB dye extracted from the lung than the sham mice. 
Administration of HC (25) prevented increased vascular permeability (sham vs. CLP 
vs. CLP + HC, P=0.0009; post hoc comparison, sham vs. CLP, P=0.0012; CLP vs. 
CLP + HC, P=0.011; sham vs. CLP + HC, P=0.80) (Figure 3A). Similar to the results 
for EB, fluorescent intensity in lungs in CLP mice was significantly higher than in the 
sham or HC pretreatment mice (sham vs. CLP, P<0.0001; CLP vs. CLP + HC, 
P<0.0001; sham vs. CLP + HC, P=0.060) (Figure 3B, 3C). The difference in 
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fluorescent intensity in lung remained significant after correction for fluorescent 
intensity in blood at 60 min (sham vs. CLP vs. CLP + HC, P=0.0011; post hoc 
comparison, sham vs. CLP, P=0.0007; CLP vs. CLP + HC, P=0.24; sham vs. CLP + 
HC, P=0.081). 
We next measured vascular permeability in the footpads of CLP mice using 
fluorescence imaging (Figure 4A). There were no significant differences in baseline 
footpad fluorescent intensity among the 3 groups (P=0.28) (Figure 4B). The 
fluorescent intensity decreased in most of the sham group (8/10, 80%) at 60 min, 
while it increased in the entire CLP group (11/11, 100%). There were significant 
differences in footpad fluorescent intensity at 60 min among the 3 groups (P<0.0001) 
(Figure 4B). In the CLP group, the fold change from baseline of footpad fluorescent 
intensity was significantly higher than in the sham or HC treatment group (sham vs. 
CLP vs. CLP + HC, P<0.0001; sham vs. CLP, P<0.0001; CLP vs. CLP + HC, 
P=0.0004; sham vs. CLP + HC, P=0.058) (Figure 4C), similar to the results for lung 
fluorescent intensity (Figure 3C). We further analyzed the correlation between 
fluorescent intensity in the footpad and lung using all experimental data. The 
fluorescent intensity in the footpad was significantly correlated with that in the lung 
(r=0.95) (Figure 5). 
 
 
Discussion 
The aim of the present study was to develop a noninvasive approach using in 
vivo fluorescence imaging to measure systemic vascular permeability in sepsis, and to 
investigate the utility of this technique. In an experiment using a local inflammation 
model, mustard oil stimulation increased footpad vascular permeability in the 
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fluorescence imaging method, as in the conventional EB dye method. In the systemic 
inflammation model, as in the conventional method, CLP increased vascular 
permeability of lung in the fluorescence imaging method. Furthermore, in the CLP 
model, the footpad fluorescent intensity was strongly correlated with that in lung. 
It has been reported that local inflammation increases fluorescent dye 
concentration in the extravascular joint space in mice with autoimmune arthritis or in 
the ear in transgenic mice with vascular hyperpermeability (10, 13). Similarly, local 
stimulation using mustard oil increased fluorescent intensity in the footpad. The NIR 
fluorescent dye Genhance 750, a small molecule with a short blood half-life, 
contributed to successful quantification of vascular permeability in the present study. 
Lung edema reduces pulmonary compliance, increases respiratory work, and 
potentially leads to hypoxemia and pulmonary hypertension (26). Increased 
extravascular lung water was associated with worse survival in patients with severe 
sepsis (27). To improve the poor clinical outcome in lung edema, vascular 
permeability has been studied in sepsis models created with CLP, using conventional 
EB dye measurement (8, 20). As previously noted, the present CLP surgery increased 
EB dye concentration in the lung. Similar to the results using the conventional EB 
method, fluorescent imaging successfully detected increased fluorescent intensity in 
the lung in CLP mice. As Genhance 750 is excreted by the kidney, impaired excretion 
may contribute to the difference in dye concentration between control and CLP 
groups at the 60 min time-point in Figure 2B (Fig 2B). However, the difference in 
fluorescent intensity in lung remained significant after correction for the fluorescent 
intensity in blood at 60 min. Thus, this method can be used to evaluate vascular 
permeability in remote organ damage (i.e., lung) associated with sepsis.  
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Systemic inflammation increases systemic vascular permeability; in sepsis, 
increased vascular permeability is observed in the lung, kidney, liver, and skin/muscle 
(28-30). Both lung edema and peripheral edema are significantly associated with poor 
outcomes in critically ill patients (31, 32). As the lung is covered by thick tissue, an 
invasive procedure to expose the lung is needed to obtain sufficient fluorescent 
signals for quantification (12, 33). In contrast to the lung, the mouse footpad was 
stably measured without an invasive procedure in fluorescent imaging experiments 
(34). Since peripheral edema in patients who underwent pleurodesis was significantly 
associated with lung edema (35), footpad edema may also be correlated with lung 
edema. Thus, we quantified the fluorescent intensity in footpads. In contrast to the 
decreased footpad fluorescent intensity from baseline at 60 min in control mice, the 
CLP mice had increased footpad fluorescent intensity compared with baseline. As the 
blood fluorescent intensity in both CLP and sham mice was significantly decreased 
over time, the fluorescent intensity might even decrease in CLP mice. This 
observation may explain the increased vascular permeability in the CLP or CLP + HC 
model, with fluorescent dye leakage into the extravascular space in the footpad. As 
expected, the fluorescent intensity in the footpad was strongly correlated with that in 
lung. 
Noninvasive real-time in vivo fluorescence imaging for assessment of vascular 
permeability in remote organs during systematic inflammation has not been reported. 
The noninvasive method using fluorescence imaging can be utilized to measure 
vascular permeability in sepsis, thus strengthening the study. We compared 
fluorescence imaging using Genhance 750 with the established EB dye method. EB 
dye is known to bind to albumin and thus allows quantification of leakage across the 
vascular barrier (15). In contrast, Genhance 750 is a small molecule and is excreted by 
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the kidney. Thus, the pharmacokinetics and ease of vascular leakage of Genhance 750 
are different from those of EB dye. To overcome these limitations, we injected 
Genhance 750 and EB dye at the same time into the same individuals. We found that 
data obtained with the Genhance 750 fluorescence method corresponded well to those 
obtained with the EB dye method in the CLP model. Thus, we concluded that this 
novel, noninvasive method can be used as an alternative to EB quantification. We 
found that the difference in fluorescent intensity in lung between CLP and control 
mice remained significant after correction for blood fluorescent intensity; however, 
fluorescent dye remaining in blood can influence quantification of fluorescent 
intensity, and is a limitation of this study. We found a strong correlation between 
fluorescent intensity in the lung and footpad; however, while the imaging of footpads 
was performed in living, anesthetized mice, the lungs were only imaged after 
sacrificing the mice and removing the lungs. Further studies in both lungs and 
footpads in live animals using different imaging devices may strengthen our findings. 
Furthermore, development of noninvasive methods to directly visualize fluorescent 
intensity in the lung during sepsis may provide more precise assessment of lung 
vascular permeability. Since our method is sensitive enough to detect the effect of HC 
on vascular permeability (25), our findings highlighted the utility of this novel 
fluorescent imaging method in the noninvasive evaluation of lung vascular 
permeability, and demonstrated the potential utility for quantification of temporal 
changes in individual mice; this method can be used to evaluate the efficacy of new 
therapeutic drugs in a preclinical study. 
 
Conclusion 
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The present noninvasive in vivo fluorescent imaging approach may be useful 
for assessment of vascular permeability based on EB quantification. The footpad 
fluorescent intensity was strongly correlated with that in the lung and appears to 
reflect systemic vascular permeability. This novel fluorescent imaging technique can 
be utilized in a preclinical study of sepsis.  
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FIGURE LEGENDS  
Figure 1. Vascular permeability in a local inflammation model.  
A. Evans blue concentration in mustard oil-treated footpads and control footpads.  
B. Temporal changes in footpad intensity. The solid line indicates the mean ± 
standard deviation value in each group and the dotted line indicates the actual value in 
each individual. 
C. The fold changes from baseline fluorescent intensity at 60 min in mustard oil-
treated footpads and control footpads.  
Data are expressed as mean ± standard deviation. P values were calculated using 
paired t-tests. 
 
Figure 2. Temporal change in blood fluorescent intensity in CLP and sham 
groups. 
A. Fluorescent imaging of blood in CLP and sham mice. Instillation of 100 µL of 
blood into 96-well plates was performed and the wells were outlined as regions of 
interest.  
B. Temporal changes in blood intensity. The solid line indicates the mean ± standard 
deviation value in each group and the dotted line indicates the actual value in each 
individual. 
Data are expressed as mean ± standard deviation. P values were calculated using 
paired t-tests. 
 
Figure 3. Lung vascular permeability in a systemic inflammation model. 
A. Evans blue concentration in lungs. 
23 
B. Fluorescent imaging in lungs. The lungs were adjoined and the right and left lungs 
were outlined as a single region of interest.   
C. Fluorescent intensity in lungs. 
Data are expressed as mean ± standard deviation. P values were calculated using one-
way analysis of variance with Tukey’s post hoc test. 
 
Figure 4. Footpad vascular permeability in a systemic inflammation model. 
A. Fluorescent imaging of footpads. Both footpads were measured and the average 
fluorescent intensity was calculated in duplicate. 
B. Temporal changes in footpad intensity. 
C. The fold changes from baseline fluorescent intensity at 60 min. 
Data are expressed as mean ± standard deviation. P values were calculated using one-
way analysis of variance with Tukey’s post hoc test. 
 
Figure 5. Correlation between footpad fluorescent intensity and lung fluorescent 
intensity. 
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